The following IRB review fees are in effect for FY2013:
Initial protocol review...$2000
The activities above are exempt from IRB review fees if:
1) the study is funded by the federal government or another non-profit entity; or
2) the study is investigator-initiated; or
3) the activity qualifies for expedited review or is declared exempt by an IRB Chair/Vice Chair.
The fees for protocols received by the IRB before September 1, 2007 remain under the previous fee schedule for the duration of the study. For specific details, please see the link below.
If you wish to request a waiver of fees, please e-mail your request to Dr. Mark Stacy, Vice Dean for Clinical Research, School of Medicine.